Bioceres Earnings Reports

Bioceres Crop Solutions posted a net loss of $7.5 million in Q1 2026. Revenue fell to $77.5 million, reflecting strategic efforts to shift away from low-margin sales. Despite this, gross margin rose to 47% due to a better product mix and cost controls. Adjusted EBITDA increased 61% year-over-year.

Bioceres saw a 40% year-over-year decline in Q4 revenue due to softer demand in Argentina and a shift in its seed business model. The company posted a net loss of $48 million and negative adjusted EBITDA, reflecting transitory impacts and margin pressures.

Bioceres delivered a net loss of $1.6 million in Q3 2025 on revenues of $60.6 million, down from $84 million a year ago. The decline was mainly due to the absence of the Syngenta downpayment recorded in the prior year. Nevertheless, operating cash flow improved significantly to $23.3 million, supported by better working capital management.

Bioceres Crop Solutions reported total revenues of $106.7 million for the fiscal second quarter ended December 31, 2024, a 24% decline from the previous year, primarily due to challenging market conditions in Argentina affecting crop protection and specialty fertilizers. Despite the revenue decline, the company's gross margin expanded to 42% due to an improved product mix, focusing on higher-margin products. Net income for the quarter was $0.6 million, and Adjusted EBITDA was $15.4 million.